On September 5th, with the completion of concrete pouring on the last roof, the main structure of the construction project of the R&D Center of Wanbangde Pharmaceutical Group was successfully completed! This marks the completion of another key node in the construction of the project, an important step forward in the overall project construction, and Wanbangde Pharmaceutical has entered a new development period.

On December 30, 2015, the R&D center building started the preliminary approval work for project design and exploration. Since the project officially started construction in September 2017, with the joint efforts of design, exploration, supervision, construction and other units, after more than a year of intense construction, the main project of the building has been successfully completed, creating a first in the history of the development of Wanbangde Pharmaceutical. new milestone.

During the whole process of the construction of the R&D center building, we have received cooperation and strong support from many aspects. The company's infrastructure department and each construction unit firmly establish the concept of safe development, keep the safety red line and bottom line, strengthen the safety awareness of the construction site operators, and create a construction atmosphere of "safety first, quality first". Leaders at all levels also attach great importance to the quality, safety and progress of the project, and conduct in-depth on-site inspections, creating favorable conditions for the smooth progress of the project. In the next step, according to the overall progress of the project, subcontracting projects such as interior decoration and installation will be launched. The R&D center building is expected to be officially put into use in the second half of 2019.

The construction project of the R&D Center Building of Wanbangde Pharmaceutical Group is located at No. 28, Baizhang North Road, Chengdong Street, Wenling City. It is built on the reserved plot on the west side of Wanbangde Pharmaceutical Factory. The total investment of the project is 198 million yuan, of which 70 million yuan is used for the research and development of consistent evaluation varieties and new drugs, and the fixed asset investment is 123 million yuan. The R&D center building is 17 floors high, with a total construction area of ​​20,609.09 square meters. After the project is completed, 180 sets of test equipment such as online TOC, X-ray powder derivatizer, and sterile isolation operating system will be added to conduct chemical raw materials and preparations. , Research and development of natural medicine products.

The construction project of the R&D center building of Wanbangde Pharmaceutical Group is an important project to improve the corporate image, enhance the core competitiveness of the company, improve the overall scientific research level, and build an intelligent manufacturing base, which will lay a solid foundation for promoting the company's transformation and upgrading.